Revenue | ₹1.54Cr |
Net Profits | ₹1.34Cr |
Net Profit Margins | 87.01% |
Biogen Pharmachem Industries Ltd’s revenue jumped 1811.11% since last year same period to ₹1.54Cr in the Q1 2025-2026. On a quarterly growth basis, Biogen Pharmachem Industries Ltd has generated 14.07% jump in its revenue since last 3-months.
Biogen Pharmachem Industries Ltd’s net profit jumped 937.5% since last year same period to ₹1.34Cr in the Q1 2025-2026. On a quarterly growth basis, Biogen Pharmachem Industries Ltd has generated 13.56% jump in its net profits since last 3-months.
Biogen Pharmachem Industries Ltd’s net profit margin fell -51.06% since last year same period to 87.01% in the Q1 2025-2026. On a quarterly growth basis, Biogen Pharmachem Industries Ltd has generated -0.45% fall in its net profit margins since last 3-months.
The revenue for Biogen Pharmachem Industries Ltd in the Q1 results 2025 was ₹1.54Cr.
The net profit for Biogen Pharmachem Industries Ltd in the Q1 results 2025 was ₹1.34Cr.
The net profit margin for Biogen Pharmachem Industries Ltd in the Q1 results 2025 was 87.01%.
The revenue for Biogen Pharmachem Industries Ltd in the Q1 results 2024 was ₹0.09Cr.
The net profit for Biogen Pharmachem Industries Ltd in the Q1 results 2024 was ₹0.16Cr.
The net profit margin for Biogen Pharmachem Industries Ltd in the Q1 results 2024 was 177.78%.